The RADIANCE CED study is looking at the long-term effects of a treatment called Ultrasound Renal Denervation (using the Paradise™ Ultrasound Renal Denervation (uRDN) System) on blood pressure. This treatment uses ultrasound energy to target nerves in the kidneys that can contribute to high blood pressure. The study wants to see if this treatment helps lower blood pressure in people with uncontrolled high blood pressure (hypertension). You might be able to join if you are 65 or older, have uncontrolled high blood pressure, and are already taking stable blood pressure medication. You cannot join if your high blood pressure is due to other conditions, you've had this treatment before, are pregnant, or have severe kidney disease. The study will measure changes in blood pressure between November 2025 and December 2029. The current status of the study is unclear.

Study design

This is an observational study, meaning researchers will collect information from existing health records of Medicare-eligible patients. It aims to include 1000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Blood pressure changes will be assessed between November 2025 and December 2029.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.